[1]于小勇,杨少宁,张晓凤.心肾综合征中西医诊治述评[J].陕西中医药大学学报,2020,(01):043-47.[doi:10.13424/j.cnki.jsctcm.2020.01.012]
 Yu Xiaoyong,Yang Shaoning,Zhang Xiaofeng.Progress in Diagnosis and Treatment of Cardiorenal Syndrome with Traditional Chinese and Western Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(01):043-47.[doi:10.13424/j.cnki.jsctcm.2020.01.012]
点击复制

心肾综合征中西医诊治述评()
分享到:

《陕西中医药大学学报》[ISSN: 2096-1340/CN: 61-1501/R]

卷:
期数:
2020年01期
页码:
043-47
栏目:
出版日期:
2020-01-30

文章信息/Info

Title:
Progress in Diagnosis and Treatment of Cardiorenal Syndrome with Traditional Chinese and Western Medicine
文章编号:
2096-1340(2020)01-0043-05
作者:
于小勇杨少宁张晓凤
陕西省中医医院,陕西 西安 710003
Author(s):
Yu Xiaoyong Yang Shaoning Zhang Xiaofeng
Shaanxi TCM Hospital, Xi’ an China, 710003
关键词:
心肾综合征机制生物标志物中医认识临床疗效
Keywords:
cardiorenal syndrome mechanism biomarker understanding of traditional Chinese medicineclinical effect
分类号:
R2-09
DOI:
10.13424/j.cnki.jsctcm.2020.01.012
文献标志码:
B
摘要:
心肾综合征是心脏功能不全和肾功能不全相互作用的复杂临床综合征,包括心脏和肾脏不同的病理生理疾病,两者互为彼此的临床危险因素。近年来,本病的发病率逐年上升,但其治疗效果并不理想,且预后较差。现从心肾综合征的分类、预测指标、发病机制及治疗等角度入手,总结中医对心肾综合征的认识和近年来的相关临床研究,以期为临床诊疗提供更多有益参考。
Abstract:
Cardiorenal syndrome is a complex clinical syndrome with the interaction of cardiac and renal insufficiency, including different pathophysiological diseases of heart and kidney, which are the clinical risk factors of each other.In recent years, the incidence of this disease has been increasing year by year, but its therapeutic effect is not ideal, and the prognosis is poor. This article starts from the classification, prediction indexes, pathogenesis and treatment of cardiorenal syndrome, and summarizes the understanding of traditional Chinese medicine on cardiorenal syndrome and the related clinical research in recent years, so as to provide more useful reference for its clinical diagnosis and treatment.

参考文献/References:

[1]Schefold J C, Filippatos G, Hasenfuss G, et al. Heart failure and kidney dysfunction: epidemiology, mechanisms and management[ J] . Nat Rev Nephrol, 2016, 12( 10) :610 -623.
[2]Adams K J, Fonarow G C, Emerman C L, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry ( ADHERE) [ J] . Am Heart J, 2005,149( 2) :209 -216.
[3]McAlister F A, Ezekowitz J, Tonelli M, et al. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study[ J] . Circulation, 2004,109( 8) :1004 -1009.
[4]Gansevoort R T, Correa - Rotter R, Hemmelgarn B R, etal. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention[ J] . Lancet, 2013,382( 9889) :339 -352.
[5]Sud M, Tangri N, Pintilie M, et al. ESRD and death after heart failure in CKD[ J] . J Am Soc Nephrol, 2015, 26( 3) :715 -722.
[6]Ronco C, Di Lullo L. Cardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches[ J] . Kidney Dis ( Basel) , 2017, 2 ( 4) : 151-163.
[7]Ronco C, McCullough P, Anker S D, et al. Cardio - renal syndromes: report from the consensus conference of the acute dialysis quality initiative [ J] . Eur Heart J,2010,31( 6) :703 -711.
[8]Takahama H, Nishikimi T, Takashio S, et al. Change in the NT - proBNP/ Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome[ J] . J Am Heart Assoc, 2019,8( 17) : e11468.
[9]Sheng X, Lin L, Guo F, et al. Copeptin level in the early prediction of cardiorenal syndrome in rats[ J] . Exp Ther Med, 2018,16( 2) :937 -944.
[10]Schefold J C, Filippatos G, Hasenfuss G, et al. Heart failure and kidney dysfunction: epidemiology, mechanisms and management[ J] . Nat Rev Nephrol, 2016, 12( 10) :610 -623.
[11]Virzi G M, Breglia A, Brocca A, et al. Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1 [ J] . Cardiorenal Med, 2018,8( 4) :321 -331.
[12]Linhart C, Ulrich C, Greinert D, et al. Systemic inflammation in acute cardiorenal syndrome: an observational pilot study[ J] . ESC Heart Fail, 2018,5( 5) :920 -930.
[13]Volpe M, Carnovali M, Mastromarino V. The natriureticpeptides system in the pathophysiology of heart failure:from molecular basis to treatment[ J] . Clin Sci ( Lond) ,2016,130( 2) :57 -77.
[14]Clementi A, Virzi G M, Battaglia G G, et al. Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome[ J] . Cardiorenal Med,2019,9( 5) :265 -273.
[15]Zannad F, Rossignol P. Cardiorenal Syndrome Revisited[ J] . Circulation, 2018,138( 9) :929 -944.
[16]李鹤,刘亚洋.益气强心方对 1型心肾综合征病人心肾功能的影响 [J].中西医结合心脑血管病杂志,2019,17(9):1390-1391.
[17]张群生.温阳益气活血方辅治Ⅱ型心肾综合征对心功能及肾功能影响[J].实用中医药杂志,2019,35(8):999-1000.
[18]冯伟,张晶,方芳.益气温阳活血利水方干预心肾综合征患者心肾功能的临床研究[J].中国循证心血管医学杂志,2019,11(9):1096-1098.
[19]王慧敏,吴英智,韦震鸣,等.真武汤治疗Ⅱ型及Ⅳ型心肾综合征的临床研究[J].实用医学杂志,2018,34(13):2255-2259.
[20]王海霞,牛燕运.温阳益气活血法对Ⅱ型心肾综合征病人心功能及肾功能的影响[J].中西医结合心脑血管病杂志,2018,16(17):2537-2539.
[21]张秀荣,薛一涛.真武汤合保元汤对 2型心肾综合征阳气亏虚证兼血瘀证心肾功能的影响[J].中国实验方剂学杂志,2018,24(9):202-207.

相似文献/References:

[1]黎美娟 叶明花 郑江明.脐疗治未病机理初探[J].陕西中医药大学学报,2019,(02):032.[doi:10.13424/j.cnki.jsctcm.2019.02.011]

备注/Memo

备注/Memo:
基金项目:陕西省科技厅社发攻关一般项目(2017SF-298);陕西省中医药管理局资助项目(15-LC024)
更新日期/Last Update: 2020-01-15